Illumina (ILMN) Total Non-Current Liabilities (2010 - 2026)
Illumina's (ILMN) quarterly Total Non-Current Liabilities came in at $3.5 billion in Q2 2026, up 1.21% on a YoY basis from $3.5 billion in Q2 2025, and little changed quarter-over-quarter from $3.5 billion in Q1 2026.
Analysis
Illumina (ILMN) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Illumina (ILMN) has reported Total Non-Current Liabilities for 17 consecutive years, with $3.5 billion the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities rose 1.21% year-over-year to $3.5 billion; the trailing twelve-month figure through Jun 2026 stood at $3.5 billion (up 1.21% YoY), and the FY2025 full-year result was $3.6 billion, down 0.84% from the prior year.
- Total Non-Current Liabilities was little changed at $3.5 billion in Q2 2026 per ILMN's latest filing, from $3.5 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $5.0 billion in Q1 2023 and bottomed at $3.5 billion in Q3 2025.
- Historically, Total Non-Current Liabilities has averaged $3.8 billion across 5 years, with a median of $3.6 billion in 2024.
- The widest YoY moves for Total Non-Current Liabilities: up 40.48% in 2023, down 25.14% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $3.9 billion in 2022, then dropped by 4.24% to $3.7 billion in 2023, then slipped by 4.14% to $3.6 billion in 2024, then retreated by 0.84% to $3.6 billion in 2025, then slipped by 1.07% to $3.5 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $3.5 billion, $3.5 billion, and $3.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 55.95 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 33.25 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 6.06 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 3.52 Bn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 4.05 Bn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 457.16 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 2.88 Bn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 821.06 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 197.96 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 3.06 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 3.52 Bn |
| Mar 29, 2026 | 3.53 Bn |
| Dec 28, 2025 | 3.56 Bn |
| Sep 28, 2025 | 3.46 Bn |
| Jun 29, 2025 | 3.48 Bn |
| Mar 30, 2025 | 3.47 Bn |
| Dec 29, 2024 | 3.59 Bn |
| Sep 29, 2024 | 3.58 Bn |
| Jun 30, 2024 | 4.31 Bn |
| Mar 31, 2024 | 3.66 Bn |
| Dec 31, 2023 | 3.75 Bn |
| Oct 1, 2023 | 3.67 Bn |
| Jul 2, 2023 | 4.52 Bn |
| Apr 2, 2023 | 4.46 Bn |
| Jan 1, 2023 | 5.00 Bn |
| Oct 2, 2022 | 3.91 Bn |
| Jul 3, 2022 | 4.15 Bn |
| Apr 3, 2022 | 3.53 Bn |
| Jan 2, 2022 | 3.56 Bn |
| Oct 3, 2021 | 3.39 Bn |